Koolen–De Vries syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Koolen–De Vries syndrome | |
|---|---|
| |
| Synonyms | 17q21.31 microdeletion syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Developmental delay, intellectual disability, hypotonia, distinctive facial features |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing |
| Differential diagnosis | Other genetic syndromes |
| Prevention | |
| Treatment | Supportive care, therapies |
| Medication | |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
Koolen–De Vries syndrome (KdVS), also known as 17q21.31 microdeletion syndrome, is a rare genetic disorder characterized by a variety of physical, neurological, and behavioral symptoms. The syndrome was first described by Dutch researchers David Koolen and Bert De Vries in 2006.
Symptoms and Signs[edit]
The symptoms of Koolen–De Vries syndrome can vary widely among affected individuals. Common symptoms include developmental delay, intellectual disability, and distinctive facial features. Other symptoms can include heart defects, seizures, and various other physical abnormalities.
Developmental Delay and Intellectual Disability[edit]
Most individuals with Koolen–De Vries syndrome experience some degree of developmental delay and intellectual disability. This can range from mild to severe, and can affect various aspects of development, including motor skills, speech and language development, and social and adaptive skills.
Distinctive Facial Features[edit]
Individuals with Koolen–De Vries syndrome often have distinctive facial features. These can include a high forehead, long face, upslanting palpebral fissures (the opening between the eyelids), and a tubular or pear-shaped nose.
Other Symptoms[edit]
Other symptoms of Koolen–De Vries syndrome can include heart defects, seizures, and various other physical abnormalities. These can include skeletal abnormalities, kidney abnormalities, and abnormalities of the genitals.
Causes[edit]
Koolen–De Vries syndrome is caused by a deletion of genetic material from the long (q) arm of chromosome 17 at a location designated q21.31. This deletion occurs as a new (de novo) mutation, which means it is generally not inherited from the parents.
Diagnosis[edit]
Diagnosis of Koolen–De Vries syndrome is based on clinical features and confirmed by genetic testing. This testing can identify the characteristic deletion of genetic material from chromosome 17.
Treatment[edit]
There is currently no cure for Koolen–De Vries syndrome. Treatment is symptomatic and supportive, and can include physical therapy, speech therapy, and educational support. Medications may be used to manage seizures and other symptoms.
See Also[edit]
NIH genetic and rare disease info[edit]
Koolen–De Vries syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Koolen–De Vries syndrome
|
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Syndromes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This syndrome related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

